Bristol-Myers Squibb (BMY) Q3 2026 Earnings Call Transcript

Powered byQuartr

Company Participants

  • Operator
  • Chuck Triano - SVP and Head of Investor Relations, Bristol Myers Squibb
  • Chris Boerner - Board Chair and CEO, Bristol Myers Squibb
  • David Elkins - CFO, Bristol Myers Squibb
  • Michael Yee - Managing Director, UBS
  • Cristian Massacesi - CMO and Head of Global Drug Development, Bristol Myers Squibb
  • Alexandria Hammond - Director, Wolfe Research
  • Adam Lenkowsky - Chief Commercialization Officer, Bristol Myers Squibb
  • Zach Dunn - VP, Guggenheim
  • Akash Tewari - Analyst, Jefferies
  • Eric Don - Analyst, William Blair
  • Carter Gould - Managing Director, Cantor
  • Courtney Breen - Analyst, Bernstein
  • Chris Schott - Managing Director, JPMorgan
  • Asad Haider - Managing Director, Goldman Sachs
  • Mohit Bansal - Managing Director, Wells Fargo
  • David Amsellem - Managing Director, Piper Sandler
  • Geoff Meacham - Managing Director, Citibank
  • Trung Huynh - Managing Director, RBC
  • Evan Seigerman - Managing Director, BMO Capital Markets